Continuous Beta-Blocker Therapy Delays Structural Deterioration after Bioprosthetic Mitral Valve Replacement

Ma, Wenrui; Tan, Yan; Shi, Qiuxia; Xu, Zhiwei

doi:10.1055/s-0039-1692651

Cited by 2 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…4D). 65 If mitral valve surgery is indicated in the presence of previous cardiac surgery, the valve can be approached through a minirightsided thoracotomy. This type of surgery performed mainly on the fibrillating heart was compared with classic redo sternotomy by Patel et al 66 Propensity matching of reoperative mitral valve cases (90 patient pairs out of more than 400) demonstrated no difference in survival, but faster mobilization, earlier discharge and a trend toward lower operating times in the minimally invasive group.…”

Section: Mitral and Tricuspid Valves Surgery Mitral Valvementioning

confidence: 99%

See 1 more Smart Citation

Cardiac Surgery 2019 Reviewed

Doenst

Bargenda

Kirov

et al. 2020

Thorac Cardiovasc Surg

View full text Add to dashboard Cite

For the year 2019, almost 25,000 published references can be found in PubMed when entering the search term “cardiac surgery.” We used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses approach for article selection and reviewed the main fields of adult cardiac surgery (i.e., coronary, valve, aortic, and heart failure surgery). The past decade has experienced an enormous development of interventional techniques that compete more and more with classic surgery. This contest was broadly visible in 2019. It peaked over the interpretation of the EXCEL trial data, where percutaneous coronary intervention and coronary artery bypass grafting (CABG) for left main disease were compared. A novel pathomechanism for CABG was proposed, potentially answering open questions in the field. In aortic valve surgery, two low-risk trials comparing transcatheter aortic valve implantation (TAVI) to classic aortic valve replacement (surgical aortic valve replacement) received attention for showing equal or superior short-term outcomes for TAVI. Longer follow-up information from recent trials became available presenting results emphasizing the need for joint decision making. While publications addressing surgery on the aorta and the mitral and tricuspid valves were less abundant, there was substantial activity regarding left ventricular assist device support and heart transplantation. This article attempts to summarize the most pertinent publications. It does not expect to be complete and cannot be free of individual interpretation. We aimed to provide a condensed summary of 2019s publications with a stimulus for in-depth reading and a basis supporting patient information.

show abstract

Section: Mitral and Tricuspid Valves Surgery Mitral Valvementioning

confidence: 99%

“…(D) Freedom from structural valve deterioration (SVD) after bioprosthetic valve replacement in patients who did (BB) or did not (non-BB) receive β blocker therapy. 65 (Reproduced with permission.) (E) Long-term survival in risk-adjusted patients who received either tricuspid valve repair or replacement for tricuspid regurgitation.…”

Section: Tricuspid Valvementioning

confidence: 99%

Cardiac Surgery 2019 Reviewed

Doenst

Bargenda

Kirov

et al. 2020

Thorac Cardiovasc Surg

View full text Add to dashboard Cite

show abstract

Modes of the bioprosthetic valve failure of the porcine and pericardial valves in the mitral position

Uchino

Murakami

Mukohara

et al. 2021

European Journal of Cardio-Thoracic Surgery

View full text Add to dashboard Cite

OBJECTIVES This study was conducted to examine the incidence and modes of the bioprosthetic valve failure of the porcine valve in the mitral position and compare them with those of the pericardial valve. METHODS This study included 240 patients (116 men [48.3%]; mean age, 74.87 ± 6.61 years) who underwent mitral valve replacement using the St. Jude Medical Epic bioprosthesis (Epic) (N = 125) or Carpentier–Edwards Perimount (CEP) pericardial valve (N = 115) from January 2000 to December 2020. RESULTS The median clinical follow-up durations in the Epic and CEP groups were 54.5 months (range, 0–111 months) and 81.5 months (range, 0–194 months), respectively. Structural valve degeneration (SVD) was observed in 9 patients (7.2%) in the Epic group and 11 patients (9.6%) in the CEP group. The rates of freedom from SVD at 3, 5 and 7 years were 97.7%, 90.5% and 75.5% in the Epic group and 100.0%, 96.1% and 90.0% in the CEP group, respectively. SVD reoperation was performed for 7 patients (5.6%) in the Epic group and 6 patients (5.2%) in the CEP group. The rates of freedom from SVD reoperation at 3, 5 and 7 years were 97.7%, 90.5% and 75.5% in the Epic group and 100%, 96.1% and 90.0% in the CEP group, respectively. Epic SVD was predominantly due to leaflet tearing, whereas CEP SVD was predominantly due to leaflet calcification and adhesion to the subvalvular apparatus. CONCLUSIONS SVD of the porcine valve was predominantly due to leaflet tearing. The rate of reoperation for SVD was slightly higher for the porcine valve in the mitral position than for the pericardial valve at adjusted survival analysis.

show abstract

Continuous Beta-Blocker Therapy Delays Structural Deterioration after Bioprosthetic Mitral Valve Replacement

Cited by 2 publications

References 9 publications

Cardiac Surgery 2019 Reviewed

Cardiac Surgery 2019 Reviewed

Modes of the bioprosthetic valve failure of the porcine and pericardial valves in the mitral position

Contact Info

Product

Resources

About